Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Laurus Labs Limited
LAURUSLABS | BSE
383.70
INR-6.05
-1.55%
LAURUSLABS | BSE
About Laurus Labs Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/09/2023
As of date
08/12/2023
Close
383.70
Open
393.45
High
396.15
Low
381.90
Laurus Labs Limited together with its subsidiaries engages in the development manufacture and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops manufactures and sells APIs and advanced intermediates for anti-retroviral (ARV) antidiabetic cardiovascular proton pump inhibitors (PPIs) oncology gastroenterology and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs anti-diabetic cardiovascular PPIs and central nervous system. In addition the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical dietary supplements and cosmeceutical products. Further it develops novel enzymatic solutions for industrial biotechnology and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad India.
View LessLAURUSLABS | BSE
Risk
17.7%
Sharpe
-0.71
Luna's Score
46/100
Recommendation
Hold
Luna says (LAURUSLABS | BSE)
What's Working
Positive Momentum
Low 6-Month Volatility (<30%)
What's not Working
Midcap (2B - 10B USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
20.9%1 month
17.7%3 months
29.0%6 months
29.4%Return
Fundamental Ratios
PE
56.50
Fwd. PE
0
Price to book
5.13
Debt to equity
0.53
Debt to assets
0.26
Ent. to EBITDA
22.50
Ent. to rev.
4.28
PEG
0
Other Fundamentals
EBITDA
10.60B
MarketCap
206.68B
MarketCap(USD)
2.48B
Div. yield
0.42
Op. margin
7.86
Erngs. growth
-84.30
Rev. growth
-22.30
Ret. on equity
9.51
Short ratio
0
Short perc.
0
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
26.85
Range1M
30.85
Range3M
65.25
Volumes: Market Activity
Rel. volume
0.86
Price X volume
21.21M
